The Risk of Immune Thrombocytopenic Purpura After Vaccination in Children and Adolescents
Open Access
- 1 February 2012
- journal article
- Published by American Academy of Pediatrics (AAP) in PEDIATRICS
- Vol. 129 (2), 248-255
- https://doi.org/10.1542/peds.2011-1111
Abstract
BACKGROUND: The risk of immune thrombocytopenic purpura (ITP) after childhood vaccines other than measles-mumps-rubella vaccine (MMR) is unknown. METHODS: Using data from 5 managed care organizations for 2000 to 2009, we identified a cohort of 1.8 million children ages 6 weeks to 17 years. Potential ITP cases were identified by using diagnostic codes and platelet counts. All cases were verified by chart review. Incidence rate ratios were calculated comparing the risk of ITP in risk (1 to 42 days after vaccination) and control periods. RESULTS: There were 197 chart-confirmed ITP cases out of 1.8 million children in the cohort. There was no elevated risk of ITP after any vaccine in early childhood other than MMR in the 12- to 19-month age group. There was a significantly elevated risk of ITP after hepatitis A vaccine at 7 to 17 years of age, and for varicella vaccine and tetanus-diphtheria-acellular pertussis vaccine at 11 to 17 years of age. For hepatitis A, varicella, and tetanus-diphtheria-acellular pertussis vaccines, elevated risks were based on one to two vaccine-exposed cases. Most cases were acute and mild with no long-term sequelae. CONCLUSIONS: ITP is unlikely after early childhood vaccines other than MMR. Because of the small number of exposed cases and potential confounding, the possible association of ITP with hepatitis A, varicella, and tetanus-diphtheria-acellular pertussis vaccines in older children requires further investigation.Keywords
This publication has 35 references indexed in Scilit:
- Thrombocytopenia after vaccination: Case reports to the US Vaccine Adverse Event Reporting System, 1990–2008Vaccine, 2011
- Genetic studies in pediatric ITP: outlook, feasibility, and requirementsAnnals of Hematology, 2010
- Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working groupBlood, 2009
- Tutorial in biostatistics: the self‐controlled case series methodStatistics in Medicine, 2005
- Temporal surveillance using scan statisticsStatistics in Medicine, 2005
- Thrombocytopenia after immunization of Canadian children, 1992 to 2001The Pediatric Infectious Disease Journal, 2003
- Short report: Idiopathic thrombocytopenic purpura and MMR vaccineArchives of Disease in Childhood, 2001
- Acute thrombocytopenic purpura following measles, mumps and rubella vaccination. A report on 23 patientsActa Paediatrica, 1993
- Thrombocytopenic Purpura after Measles VaccinationThe New England Journal of Medicine, 1981
- Thrombocytopenic purpura in measlesThe Journal of Pediatrics, 1956